Pacific Biosciences of California(PACB) - 2024 Q3 - Quarterly Results

Exhibit 99.1 PacBio Announces Third Quarter 2024 Financial Results MENLO PARK, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) – PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2024. Third quarter results: • Revenue of $40.0 million compared with$55.7 million in the prior-year period. • Instrument revenue of $16.8 million compared with$34.7 million in the prior-year period. Instrument revenue in the third quarter of 2024 included 22 Revio sequencing systems. • Consumable ...